The White House on February 5, 2026, officially launched TrumpRx.gov, a government-operated online platform aimed at helping Americans access prescription medications at substantially lower prices amid ongoing concerns over high health care costs and cost-of-living pressures. The initiative, championed by President Donald Trump and senior administration officials, represents a central component of the administration’s effort to reduce drug costs ahead of November’s midterm elections.
At a launch event on the White House campus, Mr Trump said the portal would allow patients with valid prescriptions to find more affordable pricing on dozens of widely used drugs, including weight-loss, diabetes, fertility and chronic disease medications. The site features more than 40 medicines from major pharmaceutical manufacturers that have agreed to offer “most-favored-nation” pricing — a strategy to align U.S. prices with the lowest paid in other developed countries — through direct-to-consumer channels or pharmacy coupon systems.
TrumpRx.gov does not function as a pharmacy or sell drugs directly. Instead, it serves as a searchable portal where users can compare discounted listed prices, print or download coupons for pharmacy use, or be redirected to manufacturers’ direct-to-consumer purchase sites. The White House emphasised that discounts on drugs such as GLP-1 weight-loss treatments Ozempic and Wegovy, along with fertility medicines and inhalers, could represent significant savings compared with traditional list prices.
Administration officials, including Centers for Medicare and Medicaid Services Administrator Dr. Mehmet Oz, promoted the site as a major advance in transparency and affordability, though experts note that the impact may vary for insured consumers whose out-of-pocket costs already benefit from coverage rebates and negotiated plans. White House supporters portray TrumpRx as a high-impact policy achievement that builds on the president’s wider “Most Favored Nation” pricing initiative and underscores a commitment to lowering health care expenses for American families.